To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UHMK1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
211 representative clones for gene UHMK1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_175866.4   .a 1 to 8535 1 to 8535 exact RefSeq,   8535/8535
(100 %)
0 diff
(100 %id)
CB990192 Human Placenta, placenta .a 21 to 718 28 to 732   tiling clone,   705/785
(89 %)
16 diff
(98.0 %id)
BE242645 leukopheresis .a 26 to 358 1 to 333       333/333
(100 %)
1 diff
(99.7 %id)
BG474616 eye, retinoblastoma .a 38 to 871 1 to 843       843/844
(99 %)
19 diff
(97.8 %id)
DB463329 hippocampus .a 39 to 470 1 to 432       432/433
(99 %)
5 diff
(98.9 %id)
CN359673 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 42 to 697 15 to 670       656/670
(97 %)
6 diff
(99.2 %id)
DR004496 placenta .a 42 to 692 1 to 652       652/652
(100 %)
5 diff
(99.3 %id)
BQ225071 epithelioid carcinoma, Pancreas .a 49 to 850 1 to 809       808/888
(90 %)
18 diff
(98.0 %id)
BU541306 carcinoma, cell line, Prostate .a 49 to 927 1 to 895       895/932
(96 %)
28 diff
(97.0 %id)
DN999348   .a 57 to 690 1 to 634       634/634
(100 %)
6 diff
(99.1 %id)
AJ536197 2 pooled tumors (clear cell type) .a 61 to 2960 10 to 2909 exact tiling clone,   2900/2909
(99 %)
9 diff
(99.7 %id)
BQ424438 eye, retinoblastoma .a 62 to 756 1 to 703       703/928
(75 %)
14 diff
(98.5 %id)
BU184346 melanotic melanoma, skin .a 69 to 765 10 to 706       697/876
(79 %)
16 diff
(98.2 %id)
CF593363 Human Placenta, placenta .a 70 to 857 28 to 823       796/834
(95 %)
14 diff
(98.4 %id)
BE886040 leiomyosarcoma, uterus .a 71 to 712 1 to 648       648/933
(69 %)
22 diff
(97.7 %id)
BM147821 leukopheresis .a 164 to 379 1 to 216       216/216
(100 %)
9 diff
(95.9 %id)
AK292369 testis .a 178 to 1710 1 to 1534 exact     1534/1534
(100 %)
1 diff
(100.0 %id)
DC398808 testis .a 178 to 745 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BI333581 cervical carcinoma cell line, cervix .a 179 to 859 1 to 682       682/682
(100 %)
8 diff
(98.9 %id)
BE145607 head_neck .a 401 to 782 382 to 1     Submitted on the opposite strand 382/382
(100 %)
2 diff
(99.5 %id)
BM468107 leiomyosarcoma, uterus .a 463 to 1454 1 to 1007       1007/1079
(93 %)
22 diff
(98.0 %id)
DC426789 testis .a 1284 to 1805 524 to 1       524/524
(100 %)
2 diff
(99.7 %id)
AK058195 testis .b 1 to 1135 1 to 1135 exact tiling clone, available from FLJ,   1135/1135
(100 %)
0 diff
(100 %id)
NM_001184763.1   .b 1 to 8194 1 to 8194 exact RefSeq,   8194/8194
(100 %)
0 diff
(100 %id)
BI562420 testis .b 26 to 778 6 to 755       750/772
(97 %)
12 diff
(98.5 %id)
TI_44350824   .b 26 to 778 127 to 876       750/893
(83 %)
12 diff
(98.7 %id)
BI259568 cervical carcinoma cell line, cervix .b 152 to 967 1 to 821       821/875
(93 %)
29 diff
(96.7 %id)
BC014917 Skin, melanotic melanoma. .b 171 to 2196 1 to 2026   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2026/2026
(100 %)
0 diff
(100 %id)
BE895119 melanotic melanoma, skin .b 192 to 820 1 to 630   available from MGC,   630/899
(70 %)
2 diff
(99.8 %id)
BM451184 eye, retinoblastoma .b 389 to 1279 21 to 917       897/917
(97 %)
16 diff
(98.3 %id)
BG386905 adenocarcinoma cell line, colon .b 424 to 1210 1 to 772       772/906
(85 %)
28 diff
(97.0 %id)
BG547675 lung .b 432 to 1091 1 to 657       657/657
(100 %)
5 diff
(99.3 %id)
TI_154151787   .b 441 to 1114 79 to 753       675/677
(99 %)
22 diff
(96.8 %id)
BI253163 cervical carcinoma cell line, cervix .b 608 to 1437 1 to 824       824/824
(100 %)
16 diff
(98.1 %id)
BQ216813 melanotic melanoma, skin .b 646 to 1503 7 to 866       860/870
(98 %)
16 diff
(98.2 %id)
BX281211 melanotic melanoma, skin .b 651 to 1134 1 to 484       484/484
(100 %)
0 diff
(100 %id)
BE884546 leiomyosarcoma, uterus .b 822 to 1566 1 to 745       745/840
(88 %)
27 diff
(96.8 %id)
CV571122 cornea, eye .b 931 to 1545 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BM541595 leiomyosarcoma, uterus .b 1185 to 2136 1 to 959       959/1081
(88 %)
21 diff
(98.1 %id)
N26421 melanocyte .b 1192 to 1669 1 to 481       481/482
(99 %)
5 diff
(99.0 %id)
CA867862 Pancreas, Purified pancreatic islet .b 1369 to 1842 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
EH316356   .b 1444 to 1497 1 to 54       54/54
(100 %)
0 diff
(100 %id)
CN390943 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1504 to 2154 9 to 659       651/659
(98 %)
6 diff
(99.1 %id)
BU078123 Pancreas, Purified pancreatic islet .b 1520 to 1901 1 to 382   fully sequenced,   382/382
(100 %)
0 diff
(100 %id)
BQ427419 melanotic melanoma, skin .b 1617 to 2504 1 to 891       891/891
(100 %)
11 diff
(98.8 %id)
TI_149311591   .b 1645 to 2619 1040 to 84   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 957/1014
(94 %)
26 diff
(97.5 %id)
AW418912 2 pooled tumors (clear cell type), Kidney .b 1649 to 1964 1 to 316     Submitted on the opposite strand 316/316
(100 %)
0 diff
(100 %id)
AW070394 pooled .b 1702 to 2162 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
AW029519 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1727 to 1881 155 to 1       155/155
(100 %)
0 diff
(100 %id)
BU929938 placenta .b 1729 to 2496 1 to 779       779/782
(99 %)
19 diff
(97.6 %id)
BU077868 Pancreas, Purified pancreatic islet .b 1871 to 2195 325 to 1   fully sequenced,   325/325
(100 %)
0 diff
(100 %id)
TI_154173310   .b 1886 to 2625 833 to 90     Submitted on the opposite strand 744/1217
(61 %)
22 diff
(98.2 %id)
BG056498 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .b 1895 to 2198 304 to 1       304/304
(100 %)
0 diff
(100 %id)
BG056501 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .b 1895 to 2198 304 to 1       304/304
(100 %)
0 diff
(100 %id)
BU689513 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1896 to 2619 742 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 724/724
(100 %)
2 diff
(99.8 %id)
AI249980 adenocarcinoma, Pancreas .b 1962 to 2197 236 to 1       236/236
(100 %)
0 diff
(100 %id)
CA943593 Pancreas, Purified pancreatic islet .b 2018 to 2618 601 to 1       601/601
(100 %)
1 diff
(99.9 %id)
BF447861 carcinoid, lung .b 2058 to 2622 565 to 1       565/565
(100 %)
0 diff
(100 %id)
AW466879 2 pooled tumors (clear cell type), Kidney .b 2087 to 2623 537 to 1       537/537
(100 %)
0 diff
(100 %id)
BG656418 Pancreas, Purified pancreatic islet .b 2114 to 2619 506 to 1     Submitted on the opposite strand 506/506
(100 %)
0 diff
(100 %id)
BE220342 carcinoid, lung .b 2121 to 2618 498 to 1       498/498
(100 %)
0 diff
(100 %id)
BE045615 carcinoid, lung .b 2146 to 2618 473 to 1       473/473
(100 %)
0 diff
(100 %id)
AW612743 carcinoid, lung .b 2159 to 2618 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AA833775 germinal center B cell .b 2162 to 2628 467 to 1   tiling clone,   467/467
(100 %)
0 diff
(100 %id)
BF589910 Kidney .b 2190 to 2619 430 to 1       430/430
(100 %)
0 diff
(100 %id)
H99317 melanocyte .b 2271 to 2619 349 to 1       349/351
(99 %)
2 diff
(99.5 %id)
AW073203 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .b 2405 to 2619 215 to 1       215/215
(100 %)
0 diff
(100 %id)
AW582783   .b 2468 to 2608 141 to 1       141/141
(100 %)
0 diff
(100 %id)
BX504086   .b 2611 to 3200 1 to 590   tiling clone,   590/590
(100 %)
0 diff
(100 %id)
DA244724 brain .b 2667 to 3274 2 to 609   capped   608/608
(100 %)
0 diff
(100 %id)
DA235319 brain .b 2680 to 3268 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
CD642201 Embryonic Stem cells .b 2716 to 3443 11 to 737       727/738
(98 %)
4 diff
(99.5 %id)
CV569923 cornea, eye .b 2806 to 3442 1 to 637       637/637
(100 %)
0 diff
(100 %id)
CN264695 embryonic stem cells, cell lines H1, H7, andH9 .b 2893 to 3512 1 to 620       620/620
(100 %)
0 diff
(100 %id)
AL707588 human skeletal muscle .b 2969 to 3692 17 to 740   tiling clone,   724/740
(97 %)
6 diff
(99.2 %id)
BM148461 leukopheresis .b 3053 to 3220 174 to 7       168/175
(96 %)
0 diff
(100 %id)
DA810005 brain .b 3220 to 3764 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA110509 cerebellum .b 3464 to 4015 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA226390 brain .b 3570 to 4091 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
EH350053   .b 3604 to 3683 1 to 80       80/80
(100 %)
0 diff
(100 %id)
DA212160 brain .b 3627 to 4166 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA860043 placenta .b 3632 to 4203 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AL137257 testis .b 3650 to 8166 1 to 4516   tiling clone, available from DKFZ, AAA   4516/4516
(100 %)
1 diff
(100.0 %id)
DA333615 hippocampus .b 3658 to 4243 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
AA082212   .b 3692 to 3951 1 to 260       260/260
(100 %)
0 diff
(100 %id)
AV659283 corresponding non cancerous liver tissue .b 3845 to 4221 1 to 377     Submitted on the opposite strand 377/377
(100 %)
0 diff
(100 %id)
BM453824 melanotic melanoma, skin .b 3851 to 4690 1 to 847       847/847
(100 %)
8 diff
(99.1 %id)
BC043436 testis .b 3937 to 8166 1 to 4234   available from MGC, AAA   4234/4234
(100 %)
5 diff
(99.9 %id)
CD655326 Embryonic Stem cells .b 3993 to 4768 5 to 776       772/780
(98 %)
9 diff
(98.9 %id)
DA408821 thalamus .b 4118 to 4770 2 to 655   capped   654/654
(100 %)
1 diff
(99.9 %id)
EH351880   .b 4143 to 4214 1 to 72       72/72
(100 %)
0 diff
(100 %id)
DA332638 hippocampus .b 4250 to 4832 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB216412 trachea .b 4282 to 4717 2 to 437   capped   436/442
(98 %)
1 diff
(99.8 %id)
BM476921 leiomyosarcoma, uterus .b 4287 to 5234 1 to 952       952/1075
(88 %)
46 diff
(95.8 %id)
BU177782 melanotic melanoma, skin .b 4297 to 5076 12 to 792       781/856
(91 %)
7 diff
(99.2 %id)
BU902792 leiomyosarcoma, uterus .b 4405 to 5109 1 to 714       714/801
(89 %)
17 diff
(97.9 %id)
DA227553 brain .b 4523 to 5171 2 to 651   capped   650/650
(100 %)
4 diff
(99.4 %id)
DB284166 uterus .b 4533 to 5078 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
CB044657 colon, juvenile granulosa tumor .b 4661 to 5289 24 to 653       630/653
(96 %)
7 diff
(99.0 %id)
DA248155 brain .b 4707 to 5295 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
BU509636 leiomyosarcoma, uterus .b 4807 to 5567 1 to 764       764/917
(83 %)
12 diff
(98.7 %id)
BM472733 melanotic melanoma, skin .b 4840 to 5574 1 to 741       741/1010
(73 %)
19 diff
(98.2 %id)
TI_154150447   .b 4846 to 5563 80 to 797   tiling clone,   718/719
(99 %)
15 diff
(98.0 %id)
BU902801 leiomyosarcoma, uterus .b 4871 to 5701 1 to 848       848/905
(93 %)
26 diff
(97.2 %id)
BG392499 embryonal carcinoma, cell line, testis .b 4895 to 5677 1 to 775       775/839
(92 %)
21 diff
(97.5 %id)
BC001977 Cervix, carcinoma .b 4928 to 8166 1 to 3239   available from MGC, AAA   3239/3239
(100 %)
0 diff
(100 %id)
CN425414 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 4947 to 5641 1 to 695       695/695
(100 %)
2 diff
(99.8 %id)
TI_57187468   .b 5050 to 5712 52 to 707       656/657
(99 %)
6 diff
(99.1 %id)
EH317295   .b 5080 to 5166 1 to 87       87/87
(100 %)
0 diff
(100 %id)
DA718814   .b 5281 to 5743 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
CV569213 cornea, eye .b 5298 to 5911 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BQ929578 leiomyosarcoma, uterus .b 5317 to 6249 1 to 932       932/932
(100 %)
8 diff
(99.2 %id)
BI093729 cervix .b 5436 to 6137 1 to 705       705/705
(100 %)
6 diff
(99.2 %id)
DR763406 embryonic stem .b 5516 to 6274 1 to 759       759/759
(100 %)
0 diff
(100 %id)
BM463327 embryonal carcinoma, cell line, testis .b 5592 to 6411 8 to 832       825/1068
(77 %)
24 diff
(97.8 %id)
BM454707 embryonal carcinoma, cell line, testis .b 5598 to 6619 1 to 1033       1033/1038
(99 %)
34 diff
(96.8 %id)
BU154596 melanotic melanoma, skin .b 5606 to 6466 1 to 875       875/877
(99 %)
30 diff
(96.6 %id)
EH326713   .b 5688 to 5772 1 to 85       85/85
(100 %)
0 diff
(100 %id)
DA750906   .b 5786 to 6365 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BM904442 leiomyosarcoma, uterus .b 5810 to 6645 26 to 877       852/1171
(72 %)
30 diff
(97.5 %id)
DA736360   .b 5810 to 6535 2 to 727   capped   726/726
(100 %)
3 diff
(99.6 %id)
AK026668 Human lung .b 5812 to 8166 1 to 2356   available from FLJ, AAA   2356/2356
(100 %)
4 diff
(99.9 %id)
DA463882   .b 5814 to 6377 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA019106   .b 5820 to 6333 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DA305815 hippocampus .b 5832 to 6398 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB195327 trachea .b 5832 to 6347 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
BU902733 leiomyosarcoma, uterus .b 5848 to 6744 1 to 905       905/905
(100 %)
11 diff
(98.8 %id)
CN425415 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 5892 to 6562 1 to 671       671/671
(100 %)
0 diff
(100 %id)
BQ959304 leiomyosarcoma, uterus .b 5960 to 6859 1 to 906       906/906
(100 %)
13 diff
(98.6 %id)
BM470097 melanotic melanoma, skin .b 6004 to 6778 1 to 780       780/1020
(76 %)
33 diff
(96.8 %id)
BU166639 melanotic melanoma, skin .b 6062 to 6855 1 to 804       804/875
(91 %)
19 diff
(97.9 %id)
BY996037   .b 6073 to 6768 29 to 724       696/724
(96 %)
8 diff
(98.9 %id)
DA608564   .b 6102 to 6650 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
AV659210 corresponding non cancerous liver tissue .b 6129 to 6867 1 to 738     Submitted on the opposite strand 738/764
(96 %)
10 diff
(98.7 %id)
BM806200 leiomyosarcoma, uterus .b 6157 to 7160 1 to 1017       1017/1088
(93 %)
25 diff
(97.8 %id)
BQ631004 insulinoma, Pancreas .b 6172 to 6719 8 to 556       549/556
(98 %)
6 diff
(99.0 %id)
BJ990555 hepatoblastoma .b 6176 to 6766 9 to 600       592/600
(98 %)
6 diff
(99.0 %id)
DA136405 alzheimer cortex .b 6204 to 6759 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BM724416 eye, fetal eye .b 6346 to 7035 1 to 690       690/690
(100 %)
4 diff
(99.5 %id)
BG682320 skin, squamous cell carcinoma .b 6365 to 7163 1 to 799       799/801
(99 %)
8 diff
(99.1 %id)
BM723554 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 6401 to 7035 1 to 636       636/636
(100 %)
1 diff
(99.9 %id)
BQ721861 sympathetic trunk .b 6464 to 7309 1 to 847       847/847
(100 %)
2 diff
(99.8 %id)
DA571826 whole embryo, mainly body .b 6477 to 7125 2 to 650   capped   649/651
(99 %)
2 diff
(99.7 %id)
BU172162 melanotic melanoma, skin .b 6517 to 7375 1 to 874       874/874
(100 %)
24 diff
(97.3 %id)
BU154674 melanotic melanoma, skin .b 6518 to 7314 1 to 804       804/901
(89 %)
23 diff
(97.5 %id)
BG120075 adenocarcinoma, cell line, Liver .b 6537 to 7223 1 to 690       690/690
(100 %)
3 diff
(99.6 %id)
AU253961 neuroblastoma .b 6561 to 7214 48 to 700       653/688
(94 %)
6 diff
(99.2 %id)
AV651159 corresponding non cancerous liver tissue .b 6568 to 6980 1 to 413     Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
BI599266 brain, hypothalamus .b 6577 to 7360 1 to 782       782/786
(99 %)
6 diff
(99.3 %id)
BI600365 brain, hypothalamus .b 6578 to 7506 1 to 919       919/960
(95 %)
6 diff
(99.4 %id)
TI_45211845   .b 6584 to 7506 94 to 1006       913/1047
(87 %)
37 diff
(96.5 %id)
TI_45212116   .b 6584 to 7360 90 to 864       775/868
(89 %)
5 diff
(99.5 %id)
AA331812 Embryo, 8 weeks .b 6608 to 6855 1 to 248       248/248
(100 %)
0 diff
(100 %id)
BU928512 brain, glioblastoma .b 6631 to 7400 1 to 778       778/782
(99 %)
17 diff
(97.9 %id)
BG163887 hypernephroma, cell line, Kidney .b 6636 to 7326 1 to 690       690/691
(99 %)
14 diff
(98.0 %id)
W39231 parathyroid gland, parathyroid tumor .b 6657 to 7033 1 to 378       378/379
(99 %)
3 diff
(99.3 %id)
ES314080 occipital scalp hair, skin .b 6675 to 6828 1 to 154       154/154
(100 %)
0 diff
(100 %id)
DA727792   .b 6745 to 7635 2 to 898   capped   897/897
(100 %)
24 diff
(97.4 %id)
FN047338 breast carcinoma .b 6761 to 6880 1 to 120       120/120
(100 %)
0 diff
(100 %id)
AI359727 brain, glioblastoma (pooled) .b 6774 to 7231 458 to 1       458/458
(100 %)
0 diff
(100 %id)
CD104263 Pooled-Skin .b 6782 to 7491 1 to 716       716/719
(99 %)
9 diff
(98.8 %id)
AI096425 brain, glioblastoma (pooled) .b 6797 to 7234 449 to 12   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 438/438
(100 %)
0 diff
(100 %id)
BE622062 melanotic melanoma, skin .b 6818 to 7538 1 to 722       722/1070
(67 %)
21 diff
(98.1 %id)
BQ429446 testis .b 6832 to 7580 1 to 751       751/751
(100 %)
11 diff
(98.6 %id)
CB987600 Pooled-Glandular .b 6886 to 7596 1 to 715       715/716
(99 %)
7 diff
(99.1 %id)
BM476897 leiomyosarcoma, uterus .b 6887 to 7915 1 to 1043       1043/1074
(97 %)
51 diff
(95.3 %id)
CV569543 cornea, eye .b 6889 to 7504 1 to 616       616/616
(100 %)
0 diff
(100 %id)
BE889492 leiomyosarcoma, uterus .b 6991 to 7665 1 to 671       671/913
(73 %)
13 diff
(98.6 %id)
BU165990 melanotic melanoma, skin .b 6998 to 7252 1 to 255   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 255/255
(100 %)
0 diff
(100 %id)
BG287945 bladder, transitional cell papilloma, cell line .b 7019 to 7806 1 to 793       793/879
(90 %)
7 diff
(99.3 %id)
BQ718856 sympathetic trunk .b 7030 to 7940 1 to 919       919/921
(99 %)
28 diff
(97.0 %id)
BU177636 melanotic melanoma, skin .b 7064 to 7781 1 to 727   AAA   727/870
(83 %)
19 diff
(97.9 %id)
C05255 heart .b 7088 to 7535 1 to 448       448/448
(100 %)
0 diff
(100 %id)
AA261924 germinal center B cell .b 7092 to 7418 1 to 327       327/327
(100 %)
0 diff
(100 %id)
TI_159717792   .b 7216 to 8172 1023 to 77   AAA   947/1026
(92 %)
28 diff
(97.3 %id)
CN425413 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 7255 to 7540 1 to 286       286/286
(100 %)
0 diff
(100 %id)
TI_154107978   .b 7268 to 8172 992 to 97   AAA   896/962
(93 %)
17 diff
(98.3 %id)
TI_151755771   .b 7268 to 8172 983 to 87   AAA   897/961
(93 %)
17 diff
(98.3 %id)
TI_149300061   .b 7356 to 8172 889 to 83   AAA   807/929
(86 %)
17 diff
(98.2 %id)
BI858563 breast, mammary adenocarcinoma, cell line .b 7375 to 8156 14 to 793       780/793
(98 %)
13 diff
(98.4 %id)
TI_57191485   .b 7375 to 8156 100 to 879       780/793
(98 %)
6 diff
(99.3 %id)
CA431103 cell lines, Chondrosarcoma .b 7381 to 8172 807 to 19   AAA   789/789
(100 %)
3 diff
(99.7 %id)
AW630393 2 pooled high-grade transitional celltumors, genitourinary tract .b 7403 to 7772 1 to 370       370/370
(100 %)
0 diff
(100 %id)
BU620734 cell lines, Chondrosarcoma .b 7408 to 8172 783 to 19   AAA   765/766
(99 %)
1 diff
(99.9 %id)
BM929419 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 7428 to 8141 23 to 736       714/736
(97 %)
6 diff
(99.2 %id)
BM976217 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 7431 to 8172 754 to 13   AAA   742/742
(100 %)
2 diff
(99.8 %id)
CA447291 Chondrosarcoma, Left Pelvis .b 7439 to 8172 745 to 13   AAA   733/733
(100 %)
2 diff
(99.8 %id)
BQ006709 Chondrosarcoma, Left Pelvis .b 7460 to 8172 725 to 13   AAA   713/713
(100 %)
1 diff
(99.9 %id)
CB852621 Human Lung Epithelial cells, lung .b 7464 to 8172 721 to 13   AAA   709/709
(100 %)
1 diff
(99.9 %id)
TI_154132416   .b 7471 to 8172 771 to 61   AAA   711/923
(77 %)
16 diff
(98.3 %id)
AA044756 uterus .b 7482 to 8022 1 to 537   fully sequenced,   537/537
(100 %)
4 diff
(99.3 %id)
CA431112 cell lines, Chondrosarcoma .b 7511 to 8177 685 to 19   AAA   667/667
(100 %)
0 diff
(100 %id)
DB368827   .b 7580 to 8172 588 to 1       588/591
(99 %)
13 diff
(97.9 %id)
BQ613747 insulinoma, Pancreas .b 7583 to 8172 605 to 16   AAA   590/590
(100 %)
0 diff
(100 %id)
CB050847 Prostate .b 7602 to 8172 599 to 29   AAA   571/571
(100 %)
0 diff
(100 %id)
DB305668 brain .b 7624 to 8172 549 to 1       549/549
(100 %)
0 diff
(100 %id)
BJ990556 hepatoblastoma .b 7625 to 8164 540 to 1       540/540
(100 %)
0 diff
(100 %id)
DB358737 whole embryo, mainly body .b 7626 to 8172 543 to 1       543/549
(98 %)
11 diff
(98.0 %id)
DB348041 trachea .b 7629 to 8172 546 to 1       546/546
(100 %)
3 diff
(99.5 %id)
AI807516 pooled .b 7634 to 8172 539 to 1       539/539
(100 %)
0 diff
(100 %id)
CN414485 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 7649 to 7769 1 to 121       121/121
(100 %)
0 diff
(100 %id)
AI872182 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 7687 to 8174 488 to 1       488/488
(100 %)
0 diff
(100 %id)
BE328788 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 7698 to 8194 497 to 1   tiling clone,   497/497
(100 %)
0 diff
(100 %id)
DB542218 hippocampus .b 7703 to 8172 1 to 470     Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
AI862794 lymph node, lymphoma, follicular mixed small and largecell .b 7741 to 8172 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AI521213 Kidney .b 7752 to 8172 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AA830159 germinal center B cell .b 7761 to 8172 423 to 12   AAA   412/412
(100 %)
0 diff
(100 %id)
AI571020 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 7761 to 8172 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AI637822 pooled germ cell tumors .b 7771 to 8173 403 to 1       403/403
(100 %)
0 diff
(100 %id)
BM681857 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 7773 to 8172 412 to 13   AAA   400/400
(100 %)
2 diff
(99.5 %id)
AA989038 carcinoid, lung .b 7797 to 8175 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AW197076 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 7807 to 8175 369 to 1       369/369
(100 %)
0 diff
(100 %id)
AI347920 adenocarcinoma, colon .b 7814 to 8166 366 to 14   AAA   353/353
(100 %)
0 diff
(100 %id)
AA255874 germinal center B cell .b 7816 to 8172 370 to 14   AAA   357/357
(100 %)
0 diff
(100 %id)
AI568681 B-cell, chronic lymphotic leukemia .b 7821 to 8175 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AI003555 parathyroid gland, parathyroid tumor .b 7824 to 8011 188 to 1       188/188
(100 %)
0 diff
(100 %id)
AA804492 germinal center B cell .b 7838 to 8172 358 to 24   AAA   335/335
(100 %)
0 diff
(100 %id)
W15270 parathyroid gland, parathyroid tumor .b 7845 to 8172 328 to 1       328/328
(100 %)
0 diff
(100 %id)
AA830170 germinal center B cell .b 7867 to 8172 317 to 12   AAA   306/306
(100 %)
0 diff
(100 %id)
CB044656 colon, juvenile granulosa tumor .b 7874 to 8172 315 to 17   AAA   299/299
(100 %)
2 diff
(99.4 %id)
BM460146 leiomyosarcoma, uterus .b 7949 to 8166 1 to 218   AAA   218/218
(100 %)
0 diff
(100 %id)
AI370148 ovary, tumor, 5 pooled (see description) .b 7987 to 8172 198 to 13   AAA   186/186
(100 %)
0 diff
(100 %id)
AA044677 uterus .b 7992 to 8177 186 to 1   fully sequenced,   186/186
(100 %)
2 diff
(99.0 %id)
NM_144624.2   .c 1 to 8446 1 to 8446 exact RefSeq,   8446/8446
(100 %)
0 diff
(100 %id)
BC026046 Eye, retinoblastoma .c 39 to 1387 1 to 1349 I257T tiling clone, available from MGC, AAA   1349/1349
(100 %)
1 diff
(100.0 %id)
AL834136 lymph node .d 1 to 2923 1 to 2923 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2923/2923
(100 %)
0 diff
(100 %id)
486 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI